{"disease":{"id":"indication-1","name":"Indication 1","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"pf-07853578","indication_name":"Indication 1","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-07853578","generic_name":"pf-07853578","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"[specific protein]","drug_class":"Small molecule inhibitor","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"treatment-c","indication_name":"Indication 1","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Treatment C","generic_name":"treatment-c","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"met233-and-met097","indication_name":"Indication 1","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MET233 and MET097","generic_name":"met233-and-met097","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"pf-07999415","indication_name":"No FDA-approved indications found for PF-07999415","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-07999415","generic_name":"pf-07999415","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"odm-108-part-iii","indication_name":"Indication under Phase 1 evaluation (not specified)","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ODM-108 Part III","company_name":"Orion Corporation, Orion Pharma","drug_phase":"discontinued","molecular_target":"Not publicly disclosed","drug_class":"Unknown — investigational small molecule","quality_score":null,"revenue":null,"mechanism":"ODM-108 mechanism of action is not publicly disclosed; Phase 1 evaluation focused on safety and pharmacokinetics in healthy volunteers."},{"drug_id":"odm-108-part-i","indication_name":"Indication under Phase 1 evaluation (not specified)","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ODM-108 Part I","company_name":"Orion Corporation, Orion Pharma","drug_phase":"discontinued","molecular_target":"Not disclosed","drug_class":"Small molecule (investigational)","quality_score":null,"revenue":null,"mechanism":"ODM-108 Part I mechanism of action is not publicly disclosed; Phase 1 development was terminated."},{"drug_id":"pf-07899895","indication_name":"Undisclosed indication (Phase 1 terminated)","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07899895","generic_name":"pf-07899895","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Not disclosed","drug_class":"Unknown","quality_score":null,"revenue":null,"mechanism":"Mechanism of action not disclosed; Phase 1 study terminated before pharmacological characterization."}],"offLabel":[],"totalMarketed":4,"totalPipeline":3},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}